Summary
According to the World Health Organization, 50% of all cases of blindness in Europe are preventable and 80% of all vision impairment is considered avoidable. However, early diagnostic requires comprehensive and accurate diagnosis tools. While OCT has emerged over the past two decades as the undisputed gold standard for accurate, high resolution local characterization of ophthalmic tissues, its limitation to provide wide field-of-views (FOV) over the entire eye structures has been vastly acknowledge as a key bottleneck to improve early diagnosis of eye conditions – in particular retinal vascular diseases (e.g. diabetic retinopathy).
OCTLIGHT has developed a disruptive laser source – the heart of the OCT system – enabling a step improvement over competing alternatives in the market, providing the cornerstone towards the next generation of 3-dimensional, wide-field and high-resolution imaging of the eye. Besides its superior performance compared to current competitive technology, OCTL’s swept source delivers these advantages at a competitive price, providing an unmatched value proposition– not only in ophthalmic applications but also in other fields using OCT (e.g. cardiology, dermatology, etc.).
Resonating with the fast expansion of the OCT market - expected to reach $1.8Bn by 2024 and growing at a double-digit rate – there is thus a very significant business opportunity for OCTLIGHT to gain a foothold as the lead (sub-)supplier of top tier OCT components. Hereto, the successful implementation of the present innovation project will represent a significant business opportunity for OCTLIGHT, with significant revenue/profit and job creation to be untapped in the first 5 years of commercialization. In addition, the present project is considered as a vital cornerstone to fuel OCTLIGHT’s growth, while simultaneously providing tailwind to a step performance improvement in next generation OCT systems.
OCTLIGHT has developed a disruptive laser source – the heart of the OCT system – enabling a step improvement over competing alternatives in the market, providing the cornerstone towards the next generation of 3-dimensional, wide-field and high-resolution imaging of the eye. Besides its superior performance compared to current competitive technology, OCTL’s swept source delivers these advantages at a competitive price, providing an unmatched value proposition– not only in ophthalmic applications but also in other fields using OCT (e.g. cardiology, dermatology, etc.).
Resonating with the fast expansion of the OCT market - expected to reach $1.8Bn by 2024 and growing at a double-digit rate – there is thus a very significant business opportunity for OCTLIGHT to gain a foothold as the lead (sub-)supplier of top tier OCT components. Hereto, the successful implementation of the present innovation project will represent a significant business opportunity for OCTLIGHT, with significant revenue/profit and job creation to be untapped in the first 5 years of commercialization. In addition, the present project is considered as a vital cornerstone to fuel OCTLIGHT’s growth, while simultaneously providing tailwind to a step performance improvement in next generation OCT systems.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/876984 |
| Start date: | 01-08-2019 |
| End date: | 31-12-2019 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
According to the World Health Organization, 50% of all cases of blindness in Europe are preventable and 80% of all vision impairment is considered avoidable. However, early diagnostic requires comprehensive and accurate diagnosis tools. While OCT has emerged over the past two decades as the undisputed gold standard for accurate, high resolution local characterization of ophthalmic tissues, its limitation to provide wide field-of-views (FOV) over the entire eye structures has been vastly acknowledge as a key bottleneck to improve early diagnosis of eye conditions – in particular retinal vascular diseases (e.g. diabetic retinopathy).OCTLIGHT has developed a disruptive laser source – the heart of the OCT system – enabling a step improvement over competing alternatives in the market, providing the cornerstone towards the next generation of 3-dimensional, wide-field and high-resolution imaging of the eye. Besides its superior performance compared to current competitive technology, OCTL’s swept source delivers these advantages at a competitive price, providing an unmatched value proposition– not only in ophthalmic applications but also in other fields using OCT (e.g. cardiology, dermatology, etc.).
Resonating with the fast expansion of the OCT market - expected to reach $1.8Bn by 2024 and growing at a double-digit rate – there is thus a very significant business opportunity for OCTLIGHT to gain a foothold as the lead (sub-)supplier of top tier OCT components. Hereto, the successful implementation of the present innovation project will represent a significant business opportunity for OCTLIGHT, with significant revenue/profit and job creation to be untapped in the first 5 years of commercialization. In addition, the present project is considered as a vital cornerstone to fuel OCTLIGHT’s growth, while simultaneously providing tailwind to a step performance improvement in next generation OCT systems.
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
